# Canadian Hemp Company Expands into Asian Market with New Partnership
A major Canadian hemp producer, GreenField Hemp Co., announced on March 6, 2026, a groundbreaking partnership with a Singapore-based distributor to bring hemp-derived products to several Asian markets. This move marks a significant step in the globalization of the hemp industry, as demand for sustainable and natural products continues to grow in regions historically cautious about cannabis-related goods.
Details of the Deal
GreenField Hemp Co., based in British Columbia, has signed a multi-year distribution agreement with AsiaWell Distributors, a firm specializing in health and wellness products across Singapore, Malaysia, and South Korea. The partnership will initially focus on non-intoxicating hemp products, including CBD-infused topicals, edibles, and industrial hemp materials for use in textiles and bioplastics.
According to GreenField’s CEO, Laura Bennett, the collaboration aims to tap into Asia’s burgeoning wellness market while promoting hemp as a sustainable agricultural commodity. “We see tremendous potential in Asia, where consumers are increasingly seeking natural alternatives for personal care and sustainable materials for everyday use,” Bennett said in a press release. The company plans to roll out its product line in mid-2026, pending regulatory approvals in each target country.
Why Asia Matters
Asia represents a largely untapped frontier for the hemp and CBD industry. While countries like China have a long history of hemp cultivation for industrial purposes, the use of hemp-derived cannabinoids in consumer products remains heavily restricted in many regions due to strict drug laws and cultural stigmas. However, attitudes are slowly shifting, particularly in urban centers where wellness trends are gaining traction.
Singapore, for instance, has recently relaxed some of its regulations on hemp-derived CBD, allowing for limited importation under strict quality controls. South Korea, meanwhile, legalized medical cannabis in 2018 and has shown openness to exploring hemp’s industrial applications. These incremental changes have created opportunities for international companies like GreenField to establish a foothold.
Challenges Ahead
Despite the optimism, GreenField and its partners face significant hurdles. Regulatory frameworks in Asia vary widely, and navigating import laws, labeling requirements, and cultural sensitivities will be critical to success. In Malaysia, for example, any association with cannabis—even non-intoxicating hemp—can trigger public backlash or legal scrutiny.
Additionally, competition is heating up. Other North American and European hemp companies are eyeing the same markets, while domestic producers in countries like China could pose a challenge with lower production costs. GreenField will need to differentiate itself through quality, transparency, and education to win over skeptical regulators and consumers.
Broader Implications for the Industry
This partnership signals a broader trend of hemp companies looking beyond traditional markets in North America and Europe. As saturation looms in established regions, firms are seeking growth in emerging economies where hemp’s potential—both as a wellness ingredient and a sustainable material—is just beginning to be recognized.
For the global hemp industry, success in Asia could pave the way for further regulatory reforms and trade agreements. It may also encourage investment in research to better understand how hemp products can be tailored to meet the unique needs of diverse populations. However, missteps could reinforce negative perceptions and set back progress.
GreenField’s venture into Asia is a bold test case for the industry. If successful, it could inspire other companies to follow suit, potentially transforming hemp into a truly global commodity. For now, all eyes are on how this partnership unfolds—and whether it can bridge the gap between East and West in the evolving world of hemp.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.